| Revenue growth | Q2 +14.0% YoY; H1 +15.8% (table-derived) |
|---|---|
| Margins | Q2 EBITDA margin 21.5% vs 20.0% YoY; H1 21.0% |
| Demand visibility | Ageing demographics, govt outlay, Tier-2 expansion demand |
| Management confidence | Confident on 1,000-bed scale and Jamshedpur timeline |
Growth
Q2 revenue +14.0% YoY, H1 +15.8%. Q2 EBITDA +23.9%, H1 +30.3%. ARPOB +7.1% YoY to ₹40,721.
Outlook
Jamshedpur 155-bed hospital, ₹75 Cr, commissioning Mar/Apr 2027. 1,000-bed scale target. Long-term ROCE/ROE ~25%. No explicit growth guidance.
Risks
Raipur occupancy only 16.5% (Q2). Agartala and Howrah occupancy near 55%. Other expenses rising faster than revenue.
Last quarter's promises, checked
Delivered
- EBITDA to improve YoY (Q1 guide) → Q2 EBITDA +23.9% (= BEAT)
Partly delivered
- FY27 EBITDA margin ~21% vs 19% LY → H1 21.0%, FY open (= PARTIAL)
- Jamshedpur 155 beds in Q4 FY27 → reaffirmed Mar/Apr 2027 (= PARTIAL, pending)
Missed
- Raipur ~30% exit occupancy by FY-end (Q1 ramp 17%) → Q2 16.5% (= MISS, trajectory)
- ARPOB up or stable from ₹42,350 (Q1, network) → Q2 ₹40,721 (= MISS)
Investor Presentation filed with BSE, NSE: GPTHEALTH. Summary written with AI assistance from the document.
GPT Healthcare Ltd: key numbers
- Share price
- ₹143.94
- Market cap
- ₹1,181 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 25.0×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.